Perceptive Advisors Llc - Insider Trading & Ownership

Entity
Company
Location
51 Astor Place, 10 Th Floor, New York, New York
Summary
The estimated value of insider holdings of Perceptive Advisors Llc is at least $924 M dollars as of June 27, 2024. Perceptive Advisors Llc is the 10%+ Owner of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $200 M. Perceptive Advisors Llc is the 10%+ Owner of SOLENO THERAPEUTICS INC and owns shares of SOLENO THERAPEUTICS INC (SLNO) stock worth about $117 M. Perceptive Advisors Llc is the 10%+ Owner of VBI Vaccines Inc/BC and owns shares of VBI Vaccines Inc/BC (VBIV) stock worth about $114 M. Perceptive Advisors Llc is the 10%+ Owner of ALBIREO PHARMA, INC. and owns shares of ALBIREO PHARMA, INC. stock worth about $85 M. Perceptive Advisors Llc is the Director of Astria Therapeutics, Inc. and owns shares of Astria Therapeutics, Inc. (ATXS) stock worth about $67.2 M. Perceptive Advisors Llc is the 10%+ Owner of ADMA BIOLOGICS, INC. and owns shares of ADMA BIOLOGICS, INC. (ADMA) stock worth about $59.9 M. Perceptive Advisors Llc is the 10%+ Owner of Verrica Pharmaceuticals Inc. and owns shares of Verrica Pharmaceuticals Inc. (VRCA) stock worth about $51.4 M. Perceptive Advisors Llc is the 10%+ Owner of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $45.6 M. Perceptive Advisors Llc is the 10%+ Owner of Aldeyra Therapeutics, Inc. and owns shares of Aldeyra Therapeutics, Inc. (ALDX) stock worth about $44 M. Perceptive Advisors Llc is the Director, 10%+ Owner of Solid Biosciences Inc. and owns shares of Solid Biosciences Inc. (SLDB) stock worth about $37.8 M. Perceptive Advisors Llc is the Director, 10%+ Owner of Lyra Therapeutics, Inc. and owns shares of Lyra Therapeutics, Inc. (LYRA) stock worth about $34 M. Perceptive Advisors Llc is the 10%+ Owner of AGILE THERAPEUTICS INC and owns shares of AGILE THERAPEUTICS INC (AGRX) stock worth about $18.4 M. Perceptive Advisors Llc is the Director, 10%+ Owner of Athira Pharma, Inc. and owns shares of Athira Pharma, Inc. (ATHA) stock worth about $12.9 M. Perceptive Advisors Llc is the 10%+ Owner of VYNE Therapeutics Inc. and owns shares of VYNE Therapeutics Inc. (VYNE) stock worth about $11.3 M. Perceptive Advisors Llc is the 10%+ Owner of LEAP THERAPEUTICS, INC. and owns shares of LEAP THERAPEUTICS, INC. (LPTX) stock worth about $10 M. Perceptive Advisors Llc is the Former 10% Owner of CARGO Therapeutics, Inc. and owns shares of CARGO Therapeutics, Inc. (CRGX) stock worth about $5 M. Perceptive Advisors Llc is the 10%+ Owner of Rain Therapeutics Inc. and owns shares of Rain Oncology Inc. (RAIN) stock worth about $3.01 M. Perceptive Advisors Llc is the 10%+ Owner of IsoPlexis Corp and owns shares of IsoPlexis Corp stock worth about $2.97 M. Perceptive Advisors Llc is the 10%+ Owner of Landos Biopharma, Inc. and owns shares of Landos Biopharma, Inc. (LABP) stock worth about $1.96 M. Perceptive Advisors Llc is the 10%+ Owner of CHEMBIO DIAGNOSTICS, INC. and owns shares of CHEMBIO DIAGNOSTICS, INC. stock worth about $1.65 M. Perceptive Advisors Llc is the 10%+ Owner of Quotient Ltd and owns shares of Quotient Ltd stock worth about $636 K. Perceptive Advisors Llc is the Director, 10%+ Owner of LianBio and owns shares of LianBio (LIAN) stock worth about $81.3 K.
All Insider Reports
All Insider Reports

Ownership of Perceptive Advisors Llc

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRNX Crinetics Pharmaceuticals, Inc. 10%+ Owner $200 M Apr 18, 2022
SLNO SOLENO THERAPEUTICS INC 10%+ Owner $117 M +$20.1 M +20.7% Sep 26, 2023
VBIV VBI Vaccines Inc/BC 10%+ Owner $114 M Apr 4, 2023
ALBO ALBIREO PHARMA, INC. 10%+ Owner $85 M Oct 11, 2022
ATXS Astria Therapeutics, Inc. Director $67.2 M +$60.6 M +920% Feb 1, 2024
ADMA ADMA BIOLOGICS, INC. 10%+ Owner $59.9 M Sep 28, 2021
VRCA Verrica Pharmaceuticals Inc. 10%+ Owner $51.4 M +$12.5 M +32.1% Dec 27, 2023
ACRV Acrivon Therapeutics, Inc. 10%+ Owner $45.6 M +$20 M +78.2% Apr 11, 2024
ALDX Aldeyra Therapeutics, Inc. 10%+ Owner $44 M -$1.68 M -3.69% Apr 4, 2024
SLDB Solid Biosciences Inc. Director, 10%+ Owner $37.8 M +$18.9 M +99.6% Jan 11, 2024
LYRA Lyra Therapeutics, Inc. Director, 10%+ Owner $34 M May 31, 2023
AGRX, AGXRW AGILE THERAPEUTICS INC 10%+ Owner $18.4 M Oct 13, 2021
ATHA Athira Pharma, Inc. Director, 10%+ Owner $12.9 M +$1.46 M +12.8% Dec 27, 2023
VYNE VYNE Therapeutics Inc. 10%+ Owner $11.3 M Aug 16, 2021
LPTX LEAP THERAPEUTICS, INC. 10%+ Owner $10 M Sep 24, 2021
CRGX CARGO Therapeutics, Inc. Former 10% Owner $5 M Nov 14, 2023
RAIN Rain Oncology Inc. 10%+ Owner $3.01 M Oct 7, 2021
ISO IsoPlexis Corp 10%+ Owner $2.97 M Oct 12, 2021
LABP Landos Biopharma, Inc. 10%+ Owner $1.96 M Jan 10, 2023
CEMI CHEMBIO DIAGNOSTICS, INC. 10%+ Owner $1.65 M Apr 4, 2023
QTNT Quotient Ltd 10%+ Owner $636 K Oct 31, 2022
LIAN LianBio Director, 10%+ Owner $81.3 K Feb 15, 2024
CERE Cerevel Therapeutics Holdings, Inc. Director $0 +$20 M Feb 20, 2024
MGTX MeiraGTx Holdings plc Director, 10%+ Owner Jun 6, 2024
NAUT Nautilus Biotechnology, Inc. Director, 10%+ Owner Jun 14, 2024
VAPO VAPOTHERM INC 10%+ Owner Jun 17, 2024

Insider Transactions Reported by Perceptive Advisors Llc:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership